OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Chrysin 7-O-β-D-glucuronide, a dual inhibitor of SARS-CoV-2 3CLpro and PLpro, for the prevention and treatment of COVID-19
Yi Yang, Rong Yu, Heng Xue, et al.
International Journal of Antimicrobial Agents (2023) Vol. 63, Iss. 1, pp. 107039-107039
Open Access | Times Cited: 6
Yi Yang, Rong Yu, Heng Xue, et al.
International Journal of Antimicrobial Agents (2023) Vol. 63, Iss. 1, pp. 107039-107039
Open Access | Times Cited: 6
Showing 6 citing articles:
Research progress and perspectives of dual-target inhibitors
Xiaojing Pang, Wenyan Xu, Jing Liang, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117453-117453
Closed Access
Xiaojing Pang, Wenyan Xu, Jing Liang, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117453-117453
Closed Access
Discovery of Cinnamoyl–Flavonoid Hybrid Derivatives as Inhibitors of SARS-CoV-2 Mpro and Anti-inflammatory Agents: Experimental and In Silico Insights into their Efficacy against Lipopolysaccharide-Induced Lung Injury
Kraikrit Utama, Nopawit Khamto, Atchara Janthong, et al.
European Journal of Pharmacology (2025), pp. 177636-177636
Open Access
Kraikrit Utama, Nopawit Khamto, Atchara Janthong, et al.
European Journal of Pharmacology (2025), pp. 177636-177636
Open Access
Chrysin 7-O-β-D-glucuronide is not a potential inhibitor against SARS-CoV-2 main protease
Rui Zhang, Jiahao Zhou, Haohao Yan, et al.
International Journal of Antimicrobial Agents (2024) Vol. 63, Iss. 5, pp. 107136-107136
Closed Access | Times Cited: 2
Rui Zhang, Jiahao Zhou, Haohao Yan, et al.
International Journal of Antimicrobial Agents (2024) Vol. 63, Iss. 5, pp. 107136-107136
Closed Access | Times Cited: 2
Arylamines QSAR-Based Design and Molecular Dynamics of New Phenylthiophene and Benzimidazole Derivatives with Affinity for the C111, Y268, and H73 Sites of SARS-CoV-2 PLpro Enzyme
Gianfranco Sabadini, Marco Mellado, Cesar A. Morales, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 606-606
Open Access | Times Cited: 1
Gianfranco Sabadini, Marco Mellado, Cesar A. Morales, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 606-606
Open Access | Times Cited: 1
Effect of amorphous chrysin loading in hydrophobically modified Pluronic F68 nanomicelles on its anticancer activity, stability and oral bioavailability
Harihar Narayan, Ashok Kumar Jangid, Jiten R. Sharma, et al.
RSC Pharmaceutics (2024) Vol. 1, Iss. 4, pp. 716-726
Open Access
Harihar Narayan, Ashok Kumar Jangid, Jiten R. Sharma, et al.
RSC Pharmaceutics (2024) Vol. 1, Iss. 4, pp. 716-726
Open Access
High-throughput screening of dual-target inhibitors for SARS-CoV-2 main protease and papain-like protease from Chebulae Fructus: in silico prediction and experimental verification
Changjian Wang, Yipeng Cao, Qi Yang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
Changjian Wang, Yipeng Cao, Qi Yang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
